SAN DIEGO, May 14, 2018 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforcesolutions and staffing services, is scheduled to present at three upcoming investor conferences:
Susan Salka, Chief Executive Officer of AMN Healthcare, is presenting at the conferences. An audio webcast and a copy of the investor presentation will be available on the Company's investor relations website at http://amnhealthcare.investorroom.com/eventcalendar on the days of the events. Participants will need to allow adequate time to download any software necessary for the webcast.
About AMN Healthcare
AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, mid-revenue cycle solutions, and other services. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com.
Contact:Randle ReeceDirector, Investor Relations866-861-3229Web site: http://www.amnhealthcare.com
View original content:http://www.prnewswire.com/news-releases/amn-healthcare-to-present-at-three-conferences-in-june-300647360.html
SOURCE AMN Healthcare
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All